Chow E, Poon EWM, Fok BSP, Chan JCN, & Tomlinson B. (2020). CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. Dove Medical Press.
Chicago Style (17th ed.) CitationChow E, Poon EWM, Fok BSP, Chan JCN, and Tomlinson B. CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. Dove Medical Press, 2020.
MLA (9th ed.) CitationChow E, et al. CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.